Nevan Krogan, University of California, San Francisco
Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven’t been tried before.
There are 20,000 FDA approved drugs. One of them might fight COVID-19, if we can find it.
Peter Dazeley/The Image Bank via Getty Images
Nevan Krogan, University of California, San Francisco
Among the more than 20,000 drugs approved by the FDA, there may be some that can treat COVID-19. A team at the University of California, San Francisco, is identifying possible candidates.
A colored electron microscope image of MRSA.
NIH - NIAID/flickr
As antibiotic resistance increases globally, the heat is on to find new alternatives to treat infections. Chemists can get a head start by looking at compounds produced in nature by fishes’ microbes.
The concept of a shared inheritable risk underlying mental illnesses could lead to a new paradigm shift in drug discovery,
(Unsplash/Fernando Cferdo)
Mental health is impacted by both genetic and environmental factors. But new research reveals that many mental health disorders may flow from early disturbances in fetal development.
Around 18% of previously treated TB cases are drug resistant.
Shutterstock
People with Down syndrome are at much higher risk of dementia than the general population. Knowing when cognitive changes start is critical for developing new drugs.
Miniature biomanufacturing kits like this prototype could revolutionize the pharmaceutical industry.
Amino Labs
Small-batch brewers are starting to tinker with biologic drugs to meet their own medical needs. A side effect of their success would be a disruption to how big pharma makes and distributes drugs.
People have to pass road tests – so should self-driving cars.
Africa Studio/Shutterstock.com
There’s a common, popular and well-studied method to ensure new technologies are safe and effective for public use – even if researchers don’t fully understand how they work.
High-tech ways to scan nature’s own creations.
Caleb Foster/Shutterstock.com
Pharmaceutical companies focus on small molecules they’ve devised – and can easily patent. But nature’s already come up with many antibacterial compounds that drug designers could use to make medicines.
Will blue packets replace pink ones soon?
Aleksandra Berzhets/Shutterstock.com
Researchers use an algorithm designed to help robots move to figure out what’s possible when designing new molecules in a promising class of pharmaceuticals.
Have our hopes of a drug treatment for dementia been dashed by drug company Pfizer giving up on research efforts?
from www.shutterstock.com
With the right investment, an open source drug discovery system might compete with the traditional pharmaceutical industry to deliver the drugs we need.
Dividing breast cancer cell.
royaltystockphoto.com
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco